Evolent Health Stock Performance

EVH Stock  USD 2.67  0.06  2.20%   
The firm shows a Beta (market volatility) of 0.43, which means possible diversification benefits within a given portfolio. As returns on the market increase, Evolent Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Evolent Health is expected to be smaller as well. At this point, Evolent Health has a negative expected return of -0.66%. Please make sure to confirm Evolent Health's maximum drawdown, as well as the relationship between the accumulation distribution and day typical price , to decide if Evolent Health performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Evolent Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2026. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Begin Period Cash Flow223.5 M
Total Cashflows From Investing Activities-62.9 M

Evolent Health Relative Risk vs. Return Landscape

If you would invest  416.00  in Evolent Health on November 13, 2025 and sell it today you would lose (149.00) from holding Evolent Health or give up 35.82% of portfolio value over 90 days. Evolent Health is generating negative expected returns assuming volatility of 3.5694% on return distribution over 90 days investment horizon. In other words, 32% of stocks are less volatile than Evolent, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Evolent Health is expected to under-perform the market. In addition to that, the company is 4.59 times more volatile than its market benchmark. It trades about -0.19 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of volatility.

Evolent Health Target Price Odds to finish over Current Price

The tendency of Evolent Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 2.67 90 days 2.67 
close to 99
Based on a normal probability distribution, the odds of Evolent Health to move above the current price in 90 days from now is close to 99 (This Evolent Health probability density function shows the probability of Evolent Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Evolent Health has a beta of 0.43 suggesting as returns on the market go up, Evolent Health average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Evolent Health will be expected to be much smaller as well. Additionally Evolent Health has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Evolent Health Price Density   
       Price  

Predictive Modules for Evolent Health

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Evolent Health. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Evolent Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.132.556.14
Details
Intrinsic
Valuation
LowRealHigh
0.554.147.73
Details

Evolent Health Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Evolent Health is not an exception. The market had few large corrections towards the Evolent Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Evolent Health, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Evolent Health within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.71
β
Beta against Dow Jones0.43
σ
Overall volatility
0.43
Ir
Information ratio -0.21

Evolent Health Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Evolent Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Evolent Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Evolent Health generated a negative expected return over the last 90 days
Evolent Health has high historical volatility and very poor performance
The company reported the last year's revenue of 2.55 B. Reported Net Loss for the year was (61.62 M) with profit before taxes, overhead, and interest of 378.34 M.
Evolent Health has a strong financial position based on the latest SEC filings
Over 98.0% of the company shares are held by institutions such as insurance companies

Evolent Health Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Evolent Stock often depends not only on the future outlook of the current and potential Evolent Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Evolent Health's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding114.7 M
Cash And Short Term Investments163.5 M

Evolent Health Fundamentals Growth

Evolent Stock prices reflect investors' perceptions of the future prospects and financial health of Evolent Health, and Evolent Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Evolent Stock performance.

About Evolent Health Performance

By evaluating Evolent Health's fundamental ratios, stakeholders can gain valuable insights into Evolent Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Evolent Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Evolent Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. The company was founded in 2011 and is headquartered in Arlington, Virginia. Evolent Health operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 3500 people.

Things to note about Evolent Health performance evaluation

Checking the ongoing alerts about Evolent Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Evolent Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evolent Health generated a negative expected return over the last 90 days
Evolent Health has high historical volatility and very poor performance
The company reported the last year's revenue of 2.55 B. Reported Net Loss for the year was (61.62 M) with profit before taxes, overhead, and interest of 378.34 M.
Evolent Health has a strong financial position based on the latest SEC filings
Over 98.0% of the company shares are held by institutions such as insurance companies
Evaluating Evolent Health's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Evolent Health's stock performance include:
  • Analyzing Evolent Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Evolent Health's stock is overvalued or undervalued compared to its peers.
  • Examining Evolent Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Evolent Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Evolent Health's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Evolent Health's stock. These opinions can provide insight into Evolent Health's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Evolent Health's stock performance is not an exact science, and many factors can impact Evolent Health's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Evolent Stock analysis

When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format